Market Synopsis:
Anatomic pathology leverages microscopic,
macroscopic, immunologic biochemical, and molecular examination of tissues and
organs for diagnosis of diseases. It has been witnessing the proliferation of
applications in the healthcare sector, thus, expected to observe an increase in
demand over the next couple of years. According to Market Research Future
(MRFR)’s report, the global anatomic pathology market is anticipated to strike
a steady CAGR over the forecast period. The main purpose of anatomic pathology
is the detection of abnormalities in the anatomy of the human body for tumor
management. It facilitates the diagnosis of life-threatening diseases such as
cancer, autoimmune diseases, liver disorder, etc. The rising incidences of
these diseases are expected to boost the growth trajectory of the anatomic
pathology market in the years to come.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/2409
The increasing patient population
of cancer is one of the most crucial factors responsible for catalyzing the
growth of the anatomic pathology market across the assessment period. Every
year, millions of new cases are being registered, and millions are succumbing
to the disease. This has gained the attention of the governments who are
investing in research & development for finding a cure and developing
drugs. It is prognosticated to propel the expansion of the Anatomic
Pathology Market over the assessment period.
The technological advancements
leveraged in bringing innovations are poised to have a favorable impact on the
expansion of the anatomic pathology market. Case to the point is, scientists
are merging the two areas of research - genetic sequencing and precision
medicine – for the development of effective drug regimens. It is expected to
revolutionize the future trajectory of the market. Furthermore, increasing
healthcare expenditure in conjunction with rising access to advanced healthcare
facilities is anticipated to augment the market in the forthcoming years. Also,
the increasing population of elderly adults is prognosticated to have a
positive influence on revenue creation among the market players.
Competitive Dashboard:
Abbott Diagnostics, Danaher, Roche Diagnostics, Agilent Technologies,
Thermo Fisher Scientific, AdnaGen, Abcam, Advanced Cell Diagnostics, Angsana
Molecular & Diagnostics Laboratory, Agendia, AutoGenomics, Biocartis, Biocare
Medical, CellMax Life, Digipath, Cancer Genetics, Enzo Biochem, Janssen
Diagnostic, Epic Sciences, Monogram Biosciences, Oxford Cancer Biomarkers, Nucleix,
Omnyx, RareCyte, Tecan, SAKURA FINETEK USA, and VolitionRx.
Market Segmentation:
·
By type, the global anatomic pathology market
has been segmented into instruments, consumables, and services.
·
By application, the anatomic pathology market has
been segmented into disease diagnostic (cancer, lymphom, and others), drug
discovery and developments.
·
By end-users, the global anatomic pathology
market has been segmented into hospitals, clinical office laboratories,
physician office laboratory, and others.
Regional Analysis:
The global
anatomic pathology market, by region, has been segmented into Americas, Europe,
Asia Pacific and the Middle East & Africa (MEA). Asia Pacific signifies the
potential for growth as it houses a huge proportion of the global population.
It is expected to exhibit the highest CAGR over the forecast period. North
America is currently dominating the global marketplace and is forecasted to
maintain its position over the assessment period. Europe, being an important
growth pocket, is likely to retain the second spot and grow substantially in
the years to come. However, lack of access to medical facilities in some of the
Africa regions is projected to undermine the growth of the anatomic pathology
market in the Middle East & Africa region.
Industry News:
In May 2019, researchers at Medical
College of Georgia at Augusta University have developed two new urine tests for
the accurate detection of bladder cancer, its severit, and recurrence.
In April 2019, Roche, a Swiss
multinational healthcare company, has announced the launch of new VENTANA HER2
Dual ISH DNA Probe Cocktail assay for breast and gastric cancer patients
eligible for targeted therapy. It helps in the detection of HER2 biomarker -
human epidermal growth factor receptor 2.
For More Related Infographics :
Eye
Allergy Treatment Market Research Report - Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/eye-allergy-treatment-market
Epilepsy
Market Research Report - Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/epilepsy-market
For
More Video Links:
Menstrual
Cup Market Insights 2019-2023
https://www.marketresearchfuture.com/videos/menstrual-cup-market
No comments:
Post a Comment